Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
571
datasets available to search
ShareScore release 0.9.0
Dataset results
571 results for “CLL”
CRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06128044. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00864942. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early Intervention With Acalabrutinib in Patients With High Risk CLL
ClinicalTrials.gov study NCT04660045. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01087151. IPD Sharing: Not stated. Countries: 12. Publications: 0.
Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01423032. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00593944. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CHOP Plus Mosunetuzumab as First Line in Patients With Richter´s Syndrome: a Phase II Study of the Spanish Group of CLL
ClinicalTrials.gov study NCT06926205. IPD Sharing: NO. Countries: 1. Publications: 0.
AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry
ClinicalTrials.gov study NCT06250465. IPD Sharing: NO. Countries: 1. Publications: 0.
Obinutuzumab Containing Conditioning Regimen for Patients With Poor Risk CLL or Richter's Transformation Requiring Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT03153514. IPD Sharing: NO. Countries: 1. Publications: 0.
Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.
ClinicalTrials.gov study NCT05803395. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02046928. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT01005979. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients
ClinicalTrials.gov study NCT00596336. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLL
ClinicalTrials.gov study NCT05197192. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL
ClinicalTrials.gov study NCT05515406. IPD Sharing: NO. Countries: 1. Publications: 0.
Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy
ClinicalTrials.gov study NCT00108108. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fixed-duration Therapy With Ibrutinib and Obinutuzumab (GA-101) in Treatment-naïve Patients With CLL
ClinicalTrials.gov study NCT04908228. IPD Sharing: NO. Countries: 1. Publications: 0.
Feasibility of a Whole-Food, Plant-Based Diet for Patients With Low-Risk Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT06377501. IPD Sharing: NO. Countries: 1. Publications: 0.
Determinants of the Response to BTK Degraders (BTKd) in Double Refractory CLL
ClinicalTrials.gov study NCT07099443. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00947388. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.